LUNGTX.COM

Lung Therapeutics

Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. We aim to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions. Contact Us Now For More Information. We’ve been researching cures for generations. Confidence to Breathe Easier.

http://www.lungtx.com/

OVERVIEW OF lungtx.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR LUNGTX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

June

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.6 out of 5 with 9 reviews

5 star

5

4 star

4

3 star

0

2 star

0

1 star

0

Hey there! Start your review of lungtx.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1 seconds

FAVICON PREVIEW

16x16

CONTACTS AT LUNGTX.COM

BRIAN WINDSOR

5703 ●●●●● BEND

AU●●IN , TX, 78749

US

1.51●●●●8549

JB●●●●●●●●●●●@GMAIL.COM

View this contact

GOOGLE, INC.

GOOGLE TEAM

1600 AMP●●●●●●●● PARKWAY

MOUN●●●●VIEW , CA, 94043

US

1.65●●●●4567

GO●●●●●●●●●●●@ENOM.COM

View this contact

GOOGLE, INC.

GOOGLE TEAM

1600 AMP●●●●●●●● PARKWAY

MOUN●●●●VIEW , CA, 94043

US

1.65●●●●4567

GO●●●●●●●●●●●@ENOM.COM

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2013 July 08
UPDATED: 2014 July 01
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

12

YEARS
0

MONTHS
15

DAYS

NAME SERVERS

1: dns1.name-services.com
2: dns2.name-services.com
3: dns3.name-services.com
4: dns4.name-services.com
5: dns5.name-services.com

REGISTRAR

ENOM, INC.

WHOIS : whois.enom.com

REFERRED : http://www.enom.com

CONTENT

PAGES IN
THIS WEBSITE

18

SSL

EXTERNAL LINKS

2

SITE IP

207.38.86.14

LOAD TIME

0.979 sec

SCORE

6.2

PAGE TITLE

Lung Therapeutics | lungtx.com Reviews

<META> DESCRIPTION

Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. We aim to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions. Contact Us Now For More Information. We’ve been researching cures for generations. Confidence to Breathe Easier.

<META> KEYWORDS

1 new pathways for

2 treating lung disease

3 programs

4 idiopathic pulmonary fibrosis

5 pleural effusion

6 our field

7 team

8 board of directors

9 medical advisory board

10 news

CONTENT

Page content here

KEYWORDS ON PAGE

new pathways for,treating lung disease,programs,idiopathic pulmonary fibrosis,pleural effusion,our field,team,board of directors,medical advisory board,news,careers,discover our therapies

SERVER

nginx

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Lung Therapeutics | lungtx.com Reviews

https://lungtx.com

Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. We aim to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions. Contact Us Now For More Information. We’ve been researching cures for generations. Confidence to Breathe Easier.

INTERNAL PAGES

lungtx.com

1

Programs | Lung Therapeutics, Inc.

http://lungtx.com/programs

Current programs are all associated with various types of fibrosis for which Lung Therapeutics’ compounds hold promise as new therapies. Lung Therapeutics has received orphan drug designation. From both the FDA and the European Commission for LTI-01 in the treatment of empyema. Read the press releases. Plasminogen activator inhibitor-1 suppresses pro-fibrotic responses in fibroblasts from fibrotic lungs. J Biol Chem. 2015 Feb 3., Tuesday, February 3, 2015. Plasminogen activator inhibitor-1 deficiency aug...

2

Ideopathic Pulmonary Fibrosis | Lung Therapeutics, Inc.

http://lungtx.com/node/36

Idiopathic Pulmonary Fibrosis (IPF) is defined as scar tissue of the lungs from unknown causes, perhaps genetic or in response to disease or injury. The condition results in poor efficiency in the lungs, either in passively exchanging oxygen and carbon dioxide or in fully expanding to draw in air. IPF affects about eight to ten in 100,000 people worldwide each year, and is known to be increasing. Plasminogen activator inhibitor-1 suppresses pro-fibrotic responses in fibroblasts from fibrotic lungs. Plasm...

3

Lung Disease | Lung Therapeutics, Inc.

http://lungtx.com/lung-disease

Lung disease includes a range of illnesses such as asthma, bronchitis, chronic obstructive pulmonary disease (COPD), pneumonia, lung cancer, cystic fibrosis, and other complications related to these illnesses. Pneumonia is a lung disease affecting more than 150 million people globally each year. In severe cases of pneumonia, a number of potentially dangerous complications may occur:. Empyema a collection of pus within a naturally existing anatomical cavity such as the pleural cavity. Lung Therapeutics is...

4

News | Lung Therapeutics, Inc.

http://lungtx.com/news

Five of Biotech Showcase’s Most Interesting Startups. NIH Grant to Advance Lung Therapeutics’ Empyema Drug Therapy. Austin Drug Developer Gets $1.7M NIH Grant. Emerging Company Profile: Effusion Dissolution. Orphan Drug Status Granted to Lung Therapeutics Drug by the European Commission. FDA Move Opens Funding, Market Assistance for Lung Therapeutics. Lung Therapeutics, Inc. Funded to Address Unmet Needs in Lung Injury and Disease. J Biol Chem. 2015 Feb 3., Tuesday, February 3, 2015. Am J Respir Cell Mol...

5

Orphan Drug Designation | Lung Therapeutics, Inc.

http://lungtx.com/node/80

LTI-01 Receives Orphan Drug Designation from both Food and Drug Administration (FDA) and European Commission (EC). Lung Therapeutics has received orphan drug designation from both the FDA and the EC for LTI-01 in the treatment of empyema, a condition resulting from complicated pleural effusion where overt pus (infected fluid) is present in the pleural space. Read the press releases. About Orphan Drug Designation. J Biol Chem. 2015 Feb 3., Tuesday, February 3, 2015. Targeting of Plasminogen Activator Inhi...

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

OTHER SITES

lungtung.com

Please wait... Forever

lungtung.info

Domain Default page

Web Server's Default Page. This page is generated by Plesk. The leading hosting automation software. You see this page because there is no Web site at this address. You can do the following:. Create domains and set up Web hosting using Plesk. Is a hosting control panel with simple and secure web server and website management tools. It was specially designed to help IT specialists manage web, DNS, mail and other services through a comprehensive and user-friendly GUI. Learn more about Plesk.

lungtung.net

vitinh4k.com - Ban ten mien domain lungtung

lungtung.us

vitinh4k.com - Ban ten mien domain lungtung

lungtungesan.blogspot.com

ลูกทุ่งอีสานท๊อปฮิต

ลูกทุ่งอีสานท๊อปฮิต. ลูกทุ่งอีสานท๊อปฮิต. ลูกทุ่งอีสานท๊อปฮิต. ลูกทุ่งอีสานท๊อปฮิต. ลูกทุ่งอีสานท๊อปฮิต. Sub Child Category 1. Sub Child Category 2. Sub Child Category 3. ท๊อปฮิตลูกทุ่งอีสาน. ลูกทุ่งท๊อปฮิตอีสาน. ผู้ติดตาม. ขับเคลื่อนโดย Blogger. ท๊อปฮิตลูกทุ่งอีสาน. This is featured post 2 title. This is featured post 3 title. This is featured post 4 title. This is featured post 5 title. Replace these every slider sentences with your featured post descriptions.Go to Blogger edit html and find these ...

lungtx.com

Lung Therapeutics

Lung Therapeutics pursues innovative treatments for underserved, life-threatening lung conditions. Our therapies for Idiopathic Pulmonary Fibrosis and Loculated Pleural Effusion bring hope to patients whose only treatment options may be invasive surgery or costly and ineffective drugs. We aim to create better pharmaceutical treatment options for IPF, LPE, and other underserved lung conditions. Contact Us Now For More Information. We’ve been researching cures for generations. Confidence to Breathe Easier.

lungtx.portalone.us

Lung Resources Home

I have reorganized this site to separate the transplant and Keeping Well portions into three sub-sites. My goal is to add more links for medical resources on the Internet to help people live with lung disease. THis is a renamed site. I started adding a new CF Section, with documents and links of interest to both CF patients and COPD patients. I have updated the site to fix some of the links that have changed This was update on 1/23/2007. The New COPD Forum. And the COPD Support Home page is here.

lungtxfoundation.org

Index of /

lungtxp.com

LungTXP —

NLA/TGH Lung Transplant Recipient Stories. Post Lung Transplant Complications. Your 2nd Wind – Life After Your Lung Transplant. Care of Your Incision. Your Daily Log and Microspirometer. House Cleaning and Pets. Sun Exposure and Your Skin. Hair, Eye, and Dental Care. Drug Specific Patient Assistance Programs. Diet and Nutrition After Transplant. LungTXP Patient Resource Site. In this section, we help you sort the daunting task of facing a lung transplant with multiple resources and education links.

lungu-hamburg.de

Webseite

Für Gastronomie, Handwerk und Handel -. Tel: 0174/ 205 72 77. E-Mail: mihaela loredana79@yahoo.com.

lungu-irimies.ro

Lungu & Irimie SCA

Lungu and Irimies - SCA. Lungu and Irimies - SCA.